Huaren Pharmaceutical: Sodium Lactate Ringer's Injection Passes Consistency Evaluation for Generic Drugs

2026-03-26 16:06:33

People’s Financial News, March 25 — Huaren Pharmaceutical (300110) announced on March 25 that the company has received the “Drug Supplementary Application Approval Notice” from the National Medical Products Administration for Sodium Lactate Ringer’s Injection (specification: 500ml). The drug has passed the consistency evaluation of quality and efficacy for generic drugs. Sodium Lactate Ringer’s Injection is a medication used to regulate body fluids, electrolytes, and acid-base balance, suitable for patients with metabolic acidosis or dehydration with metabolic acidosis.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes